First, gliomas and tumor-associated cells, including lymphocytes, can express immune checkpoint molecules such as programmed death receptor Ligand-1 (PD-L1) [118,119,120], which binds to Programmed Death Receptor-1 (PD-1) on T-cells, blocking T-cell differentiation and activation. This evidence concerns the gene CD274 and central nervous system cancer.